ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mumps Virus Vaccine Live Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-37J18368
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Mumps Virus Vaccine Live Market Research Report 2024
BUY CHAPTERS

Global Mumps Virus Vaccine Live Market Research Report 2024

Code: QYRE-Auto-37J18368
Report
October 2024
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Sinovac
AIM Vaccine
Shanghai Institute of Biological Products

Mumps Virus Vaccine Live Market

The mumps virus vaccine live is a live virus vaccine prepared using attenuated technology. It is used to prevent mumps, an acute respiratory infectious disease caused by the mumps virus. The virus contained in the vaccine has been weakened and will not cause disease, but can stimulate the body to produce immunity. After vaccination, it can effectively improve the resistance of children and adolescents to mumps and reduce the incidence rate. In my country, it is generally recommended that children aged 1-15 and adults who have not had mumps should be vaccinated with this vaccine.
The global Mumps Virus Vaccine Live market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mumps Virus Vaccine Live is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mumps Virus Vaccine Live is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mumps Virus Vaccine Live include Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mumps Virus Vaccine Live, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mumps Virus Vaccine Live.
The Mumps Virus Vaccine Live market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mumps Virus Vaccine Live market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mumps Virus Vaccine Live manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mumps Virus Vaccine Live Market Report

Report Metric Details
Report Name Mumps Virus Vaccine Live Market
by Type
by Application
  • Children
  • Adults
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mumps Virus Vaccine Live manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mumps Virus Vaccine Live in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mumps Virus Vaccine Live Market report?

Ans: The main players in the Mumps Virus Vaccine Live Market are Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products

What are the Application segmentation covered in the Mumps Virus Vaccine Live Market report?

Ans: The Applications covered in the Mumps Virus Vaccine Live Market report are Children, Adults

What are the Type segmentation covered in the Mumps Virus Vaccine Live Market report?

Ans: The Types covered in the Mumps Virus Vaccine Live Market report are Single-dose Medication, Combination Medication

Recommended Reports

Virus Vaccine Markets

Pediatric & Adult Vaccines

Vaccine Industry Supply

1 Mumps Virus Vaccine Live Market Overview
1.1 Product Definition
1.2 Mumps Virus Vaccine Live by Type
1.2.1 Global Mumps Virus Vaccine Live Market Value Comparison by Type (2024-2030)
1.2.2 Single-dose Medication
1.2.3 Combination Medication
1.3 Mumps Virus Vaccine Live by Application
1.3.1 Global Mumps Virus Vaccine Live Market Value by Application (2024-2030)
1.3.2 Children
1.3.3 Adults
1.4 Global Mumps Virus Vaccine Live Market Size Estimates and Forecasts
1.4.1 Global Mumps Virus Vaccine Live Revenue 2019-2030
1.4.2 Global Mumps Virus Vaccine Live Sales 2019-2030
1.4.3 Global Mumps Virus Vaccine Live Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mumps Virus Vaccine Live Market Competition by Manufacturers
2.1 Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mumps Virus Vaccine Live Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mumps Virus Vaccine Live Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mumps Virus Vaccine Live, Product Type & Application
2.7 Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Enter into This Industry
2.8 Global Mumps Virus Vaccine Live Market Competitive Situation and Trends
2.8.1 Global Mumps Virus Vaccine Live Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mumps Virus Vaccine Live Players Market Share by Revenue
2.8.3 Global Mumps Virus Vaccine Live Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mumps Virus Vaccine Live Market Scenario by Region
3.1 Global Mumps Virus Vaccine Live Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mumps Virus Vaccine Live Sales by Region: 2019-2030
3.2.1 Global Mumps Virus Vaccine Live Sales by Region: 2019-2024
3.2.2 Global Mumps Virus Vaccine Live Sales by Region: 2025-2030
3.3 Global Mumps Virus Vaccine Live Revenue by Region: 2019-2030
3.3.1 Global Mumps Virus Vaccine Live Revenue by Region: 2019-2024
3.3.2 Global Mumps Virus Vaccine Live Revenue by Region: 2025-2030
3.4 North America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.4.1 North America Mumps Virus Vaccine Live Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mumps Virus Vaccine Live Sales by Country (2019-2030)
3.4.3 North America Mumps Virus Vaccine Live Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mumps Virus Vaccine Live Market Facts & Figures by Country
3.5.1 Europe Mumps Virus Vaccine Live Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mumps Virus Vaccine Live Sales by Country (2019-2030)
3.5.3 Europe Mumps Virus Vaccine Live Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mumps Virus Vaccine Live Market Facts & Figures by Region
3.6.1 Asia Pacific Mumps Virus Vaccine Live Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mumps Virus Vaccine Live Sales by Region (2019-2030)
3.6.3 Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mumps Virus Vaccine Live Market Facts & Figures by Country
3.7.1 Latin America Mumps Virus Vaccine Live Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mumps Virus Vaccine Live Sales by Country (2019-2030)
3.7.3 Latin America Mumps Virus Vaccine Live Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mumps Virus Vaccine Live Market Facts & Figures by Country
3.8.1 Middle East and Africa Mumps Virus Vaccine Live Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mumps Virus Vaccine Live Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mumps Virus Vaccine Live Sales by Type (2019-2030)
4.1.1 Global Mumps Virus Vaccine Live Sales by Type (2019-2024)
4.1.2 Global Mumps Virus Vaccine Live Sales by Type (2025-2030)
4.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Type (2019-2030)
4.2 Global Mumps Virus Vaccine Live Revenue by Type (2019-2030)
4.2.1 Global Mumps Virus Vaccine Live Revenue by Type (2019-2024)
4.2.2 Global Mumps Virus Vaccine Live Revenue by Type (2025-2030)
4.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Type (2019-2030)
4.3 Global Mumps Virus Vaccine Live Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mumps Virus Vaccine Live Sales by Application (2019-2030)
5.1.1 Global Mumps Virus Vaccine Live Sales by Application (2019-2024)
5.1.2 Global Mumps Virus Vaccine Live Sales by Application (2025-2030)
5.1.3 Global Mumps Virus Vaccine Live Sales Market Share by Application (2019-2030)
5.2 Global Mumps Virus Vaccine Live Revenue by Application (2019-2030)
5.2.1 Global Mumps Virus Vaccine Live Revenue by Application (2019-2024)
5.2.2 Global Mumps Virus Vaccine Live Revenue by Application (2025-2030)
5.2.3 Global Mumps Virus Vaccine Live Revenue Market Share by Application (2019-2030)
5.3 Global Mumps Virus Vaccine Live Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Mumps Virus Vaccine Live Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Mumps Virus Vaccine Live Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Mumps Virus Vaccine Live Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Mumps Virus Vaccine Live Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SINOVAC
6.3.1 SINOVAC Company Information
6.3.2 SINOVAC Description and Business Overview
6.3.3 SINOVAC Mumps Virus Vaccine Live Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SINOVAC Mumps Virus Vaccine Live Product Portfolio
6.3.5 SINOVAC Recent Developments/Updates
6.4 AIM Vaccine
6.4.1 AIM Vaccine Company Information
6.4.2 AIM Vaccine Description and Business Overview
6.4.3 AIM Vaccine Mumps Virus Vaccine Live Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AIM Vaccine Mumps Virus Vaccine Live Product Portfolio
6.4.5 AIM Vaccine Recent Developments/Updates
6.5 Shanghai Institute of Biological Products
6.5.1 Shanghai Institute of Biological Products Company Information
6.5.2 Shanghai Institute of Biological Products Description and Business Overview
6.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product Portfolio
6.5.5 Shanghai Institute of Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mumps Virus Vaccine Live Industry Chain Analysis
7.2 Mumps Virus Vaccine Live Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mumps Virus Vaccine Live Production Mode & Process
7.4 Mumps Virus Vaccine Live Sales and Marketing
7.4.1 Mumps Virus Vaccine Live Sales Channels
7.4.2 Mumps Virus Vaccine Live Distributors
7.5 Mumps Virus Vaccine Live Customers
8 Mumps Virus Vaccine Live Market Dynamics
8.1 Mumps Virus Vaccine Live Industry Trends
8.2 Mumps Virus Vaccine Live Market Drivers
8.3 Mumps Virus Vaccine Live Market Challenges
8.4 Mumps Virus Vaccine Live Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
GSK
Sinovac
AIM Vaccine
Shanghai Institute of Biological Products
List of Tables
 Table 1. Global Mumps Virus Vaccine Live Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Mumps Virus Vaccine Live Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Mumps Virus Vaccine Live Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Mumps Virus Vaccine Live Sales (KG) of Key Manufacturers (2019-2024)
 Table 5. Global Mumps Virus Vaccine Live Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Mumps Virus Vaccine Live Average Price (US$/G) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Mumps Virus Vaccine Live, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mumps Virus Vaccine Live, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mumps Virus Vaccine Live, Product Type & Application
 Table 12. Global Key Manufacturers of Mumps Virus Vaccine Live, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mumps Virus Vaccine Live by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Virus Vaccine Live as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Mumps Virus Vaccine Live Sales by Region (2019-2024) & (KG)
 Table 18. Global Mumps Virus Vaccine Live Sales Market Share by Region (2019-2024)
 Table 19. Global Mumps Virus Vaccine Live Sales by Region (2025-2030) & (KG)
 Table 20. Global Mumps Virus Vaccine Live Sales Market Share by Region (2025-2030)
 Table 21. Global Mumps Virus Vaccine Live Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2019-2024)
 Table 23. Global Mumps Virus Vaccine Live Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Mumps Virus Vaccine Live Revenue Market Share by Region (2025-2030)
 Table 25. North America Mumps Virus Vaccine Live Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Mumps Virus Vaccine Live Sales by Country (2019-2024) & (KG)
 Table 27. North America Mumps Virus Vaccine Live Sales by Country (2025-2030) & (KG)
 Table 28. North America Mumps Virus Vaccine Live Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Mumps Virus Vaccine Live Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Mumps Virus Vaccine Live Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Mumps Virus Vaccine Live Sales by Country (2019-2024) & (KG)
 Table 32. Europe Mumps Virus Vaccine Live Sales by Country (2025-2030) & (KG)
 Table 33. Europe Mumps Virus Vaccine Live Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Mumps Virus Vaccine Live Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Mumps Virus Vaccine Live Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Mumps Virus Vaccine Live Sales by Region (2019-2024) & (KG)
 Table 37. Asia Pacific Mumps Virus Vaccine Live Sales by Region (2025-2030) & (KG)
 Table 38. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Mumps Virus Vaccine Live Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mumps Virus Vaccine Live Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Mumps Virus Vaccine Live Sales by Country (2019-2024) & (KG)
 Table 42. Latin America Mumps Virus Vaccine Live Sales by Country (2025-2030) & (KG)
 Table 43. Latin America Mumps Virus Vaccine Live Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Mumps Virus Vaccine Live Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2019-2024) & (KG)
 Table 47. Middle East and Africa Mumps Virus Vaccine Live Sales by Country (2025-2030) & (KG)
 Table 48. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Mumps Virus Vaccine Live Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Mumps Virus Vaccine Live Sales (KG) by Type (2019-2024)
 Table 51. Global Mumps Virus Vaccine Live Sales (KG) by Type (2025-2030)
 Table 52. Global Mumps Virus Vaccine Live Sales Market Share by Type (2019-2024)
 Table 53. Global Mumps Virus Vaccine Live Sales Market Share by Type (2025-2030)
 Table 54. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2019-2024)
 Table 57. Global Mumps Virus Vaccine Live Revenue Market Share by Type (2025-2030)
 Table 58. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2019-2024)
 Table 59. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2025-2030)
 Table 60. Global Mumps Virus Vaccine Live Sales (KG) by Application (2019-2024)
 Table 61. Global Mumps Virus Vaccine Live Sales (KG) by Application (2025-2030)
 Table 62. Global Mumps Virus Vaccine Live Sales Market Share by Application (2019-2024)
 Table 63. Global Mumps Virus Vaccine Live Sales Market Share by Application (2025-2030)
 Table 64. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Mumps Virus Vaccine Live Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2019-2024)
 Table 67. Global Mumps Virus Vaccine Live Revenue Market Share by Application (2025-2030)
 Table 68. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2019-2024)
 Table 69. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2025-2030)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
 Table 73. Merck Mumps Virus Vaccine Live Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
 Table 78. GSK Mumps Virus Vaccine Live Product
 Table 79. GSK Recent Developments/Updates
 Table 80. SINOVAC Company Information
 Table 81. SINOVAC Description and Business Overview
 Table 82. SINOVAC Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
 Table 83. SINOVAC Mumps Virus Vaccine Live Product
 Table 84. SINOVAC Recent Developments/Updates
 Table 85. AIM Vaccine Company Information
 Table 86. AIM Vaccine Description and Business Overview
 Table 87. AIM Vaccine Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
 Table 88. AIM Vaccine Mumps Virus Vaccine Live Product
 Table 89. AIM Vaccine Recent Developments/Updates
 Table 90. Shanghai Institute of Biological Products Company Information
 Table 91. Shanghai Institute of Biological Products Description and Business Overview
 Table 92. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
 Table 93. Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product
 Table 94. Shanghai Institute of Biological Products Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Mumps Virus Vaccine Live Distributors List
 Table 98. Mumps Virus Vaccine Live Customers List
 Table 99. Mumps Virus Vaccine Live Market Trends
 Table 100. Mumps Virus Vaccine Live Market Drivers
 Table 101. Mumps Virus Vaccine Live Market Challenges
 Table 102. Mumps Virus Vaccine Live Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mumps Virus Vaccine Live
 Figure 2. Global Mumps Virus Vaccine Live Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mumps Virus Vaccine Live Market Share by Type: 2023 & 2030
 Figure 4. Single-dose Medication Product Picture
 Figure 5. Combination Medication Product Picture
 Figure 6. Global Mumps Virus Vaccine Live Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Mumps Virus Vaccine Live Market Share by Application: 2023 & 2030
 Figure 8. Children
 Figure 9. Adults
 Figure 10. Global Mumps Virus Vaccine Live Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Mumps Virus Vaccine Live Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Mumps Virus Vaccine Live Sales (2019-2030) & (KG)
 Figure 13. Global Mumps Virus Vaccine Live Average Price (US$/G) & (2019-2030)
 Figure 14. Mumps Virus Vaccine Live Report Years Considered
 Figure 15. Mumps Virus Vaccine Live Sales Share by Manufacturers in 2023
 Figure 16. Global Mumps Virus Vaccine Live Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Mumps Virus Vaccine Live Players: Market Share by Revenue in Mumps Virus Vaccine Live in 2023
 Figure 18. Mumps Virus Vaccine Live Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Mumps Virus Vaccine Live Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Mumps Virus Vaccine Live Sales Market Share by Country (2019-2030)
 Figure 21. North America Mumps Virus Vaccine Live Revenue Market Share by Country (2019-2030)
 Figure 22. United States Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Mumps Virus Vaccine Live Sales Market Share by Country (2019-2030)
 Figure 25. Europe Mumps Virus Vaccine Live Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Mumps Virus Vaccine Live Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Mumps Virus Vaccine Live Revenue Market Share by Region (2019-2030)
 Figure 33. China Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Mumps Virus Vaccine Live Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Mumps Virus Vaccine Live Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Mumps Virus Vaccine Live Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Mumps Virus Vaccine Live Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Mumps Virus Vaccine Live by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Mumps Virus Vaccine Live by Type (2019-2030)
 Figure 52. Global Mumps Virus Vaccine Live Price (US$/G) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Mumps Virus Vaccine Live by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Mumps Virus Vaccine Live by Application (2019-2030)
 Figure 55. Global Mumps Virus Vaccine Live Price (US$/G) by Application (2019-2030)
 Figure 56. Mumps Virus Vaccine Live Value Chain
 Figure 57. Mumps Virus Vaccine Live Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Mumps Virus Testing Market Research Report 2024
Global Live Poultry Vaccine Market Research Report 2025
Global Live Vaccines Market Research Report 2024
Global Mumps Vaccine Market Research Report 2025
Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Global Measles and Rubella Vaccine Market Research Report 2025
Global Poultry Live Vaccines Market Research Report 2025
Global Live Herpes Zoster Vaccine Market Research Report 2024
Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mumps Market Research Report 2024
Global Live Attenuated Influenza Vaccine LAIV Market Research Report 2025
Global Live type Poultry Vaccine Market Research Report 2025
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Global Live Attenuated Vaccine for Pig Market Research Report 2024
Global Coccidia Virus Live Vaccine Market Research Report 2025
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Vaccine for Humans Market Research Report 2024
Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions